Results: 2

Malignant hyperthermia: what we may need to have at hand

Rev. colomb. anestesiol; 49 (4), 2021
Malignant hyperthermia (MH) is often neglected in anesthesia because of its rare incidence (around 1:100,000 general anesthetics). However, when it occurs, it becomes the anesthesiologist's nightmare. In the United States, Canada, and in most European countries, it is mandatory to store dantrolene wherev...

Cost-benefit relationship of keeping dantrolene stocks from the point of view of healthcare institutions

Rev. colomb. anestesiol; 48 (2), 2020
Abstract Introduction: Malignant hyperthermia (MH) is an acute syndrome triggered by certain anesthetic medications. Dantrolene is the only specific treatment for MH crises. Without treatment, lethality may be as high as 80%. In Colombia, it is not mandatory to keep dantrolene supplies in stock. Object...